-+ 0.00%
-+ 0.00%
-+ 0.00%

B of A Securities Initiates Coverage On Apnimed with Buy Rating, Announces Price Target of $41

Benzinga·08/25/2026 10:49:50
Listen to the news
B of A Securities analyst Jason Gerberry initiates coverage on Apnimed (NASDAQ:APMD) with a Buy rating and announces Price Target of $41.